A comparison of the bacterial CYP51 cytochrome P450 enzymes from Mycobacterium marinum and Mycobacterium tuberculosis

被引:5
|
作者
Mohamed, Hebatalla [1 ]
Child, Stella A. [1 ]
Bruning, John B. [2 ]
Bell, Stephen G. [1 ]
机构
[1] Univ Adelaide, Dept Chem, Adelaide, SA 5005, Australia
[2] Univ Adelaide, Sch Biol Sci, Adelaide, SA 5005, Australia
基金
澳大利亚研究理事会;
关键词
Lanosterol; Heme enzymes; Steroid metabolism; Cytochrome P450; Mycobacterium; CRYSTAL-STRUCTURE; STEROL; 14-ALPHA-DEMETHYLASE; BIOPHYSICAL CHARACTERIZATION; STRUCTURAL BASIS; BURULI ULCER; SPACE-GROUP; P450; IDENTIFICATION; RESOLUTION; BINDING;
D O I
10.1016/j.jsbmb.2022.106097
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Members of the CYP51 family of cytochrome P450 enzymes are classified as sterol demethylases involved in the metabolic formation of cholesterol and related derivatives. The CYP51 enzyme from Mycobacterium marinum was studied and compared to its counterpart from Mycobacterium tuberculosis to determine the degree of functional conservation between them. Spectroscopic analyses of substrate and inhibitor binding of the purified CYP51 enzymes from M. marinum and M. tuberculosis were performed. The catalytic oxidation of lanosterol and related steroids was investigated. M. marinum CYP51 was structurally characterized by X-ray crystallography. The CYP51 enzyme of M. marinum is sequentially closely related to CYP51B1 from M. tuberculosis. However, differences in the heme spin state of each enzyme were observed upon the addition of steroids and other ligands. Both enzymes displayed different binding properties to those reported for the CYP51-Fdx fusion protein from the bacterium Methylococcus capsulatus. The enzymes were able to oxidatively demethylate lanosterol to generate 14demethylanosterol, but no products were detected for the related species dihydrolanosterol and eburicol. The crystal structure of CYP51 from M. marinum in the absence of added substrate but with a Bis-Tris molecule within the active site was resolved. The CYP51 enzyme of M. marinum displays differences in how steroids and other ligands bind compared to the M. tuberculosis enzyme. This was related to structural differences between the two enzymes. Overall, both of these CYP51 enzymes from mycobacterial species displayed significant differences to the CYP51 enzymes of eukaryotic species and the bacterial CYP51-Fdx enzyme of Me. capsulatus.
引用
收藏
页数:14
相关论文
共 50 条
  • [21] Three-dimensional modeling of cytochrome P450 14α-demethylase (CYP51) and interaction of azole fungicide metconazole with CYP51
    Ito, A
    Sudo, K
    Kumazawa, S
    Kikuchi, M
    Chuman, H
    NEW DISCOVERIES IN AGROCHEMICALS, 2005, 892 : 142 - 150
  • [22] Structural biology and biochemistry of cytochrome P450 systems in Mycobacterium tuberculosis
    McLean, Kirsty J.
    Munro, Andrew W.
    DRUG METABOLISM REVIEWS, 2008, 40 (03) : 427 - 446
  • [23] Potential drug targets in the Mycobacterium tuberculosis cytochrome P450 system
    de Montellano, Paul R. Ortiz
    JOURNAL OF INORGANIC BIOCHEMISTRY, 2018, 180 : 235 - 245
  • [24] Analysis of the cytochrome P450 complement in the human pathogen Mycobacterium tuberculosis
    Clift, D
    Seward, HE
    Balding, PR
    Sutcliffe, MJ
    Warman, AJ
    Sabri, M
    McLean, KJ
    Munro, AW
    Proceedings of the 14th International Conference on Cytochromes P450: Biochemistry, Biophysics, and Bioinformatics, 2005, : 133 - 136
  • [25] Cloning and characterization of CYP51 from Mycobacterium avium
    Pietila, Michael P.
    Vohra, Pawan K.
    Sanyal, Bharati
    Wengenack, Nancy L.
    Raghavakaimal, Sreekumar
    Thomas, Charles F., Jr.
    AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2006, 35 (02) : 236 - 242
  • [26] Crystallization and preliminary crystallographic analysis of a novel cytochrome P450 from Mycobacterium tuberculosis
    Mowat, CG
    Leys, D
    McLean, KJ
    Rivers, SL
    Richmond, A
    Munro, AW
    Lombardia, MO
    Alzari, PM
    Reid, GA
    Stephen, KCB
    Walkinshaw, MD
    ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 2002, 58 : 704 - 705
  • [27] The characterisation of two members of the cytochrome P450 CYP150 family: CYP150A5 and CYP150A6 from Mycobacterium marinum
    Child, Stella A.
    Flint, Kate L.
    Bruning, John B.
    Bell, Stephen G.
    BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2019, 1863 (05): : 925 - 934
  • [28] Trypanosoma cruzi CYP51 Inhibitor Derived from a Mycobacterium tuberculosis Screen Hit
    Chen, Chiung-Kuang
    Doyle, Patricia S.
    Yermalitskaya, Liudmila V.
    Mackey, Zachary B.
    Ang, Kenny K. H.
    McKerrow, James H.
    Podust, Larissa M.
    PLOS NEGLECTED TROPICAL DISEASES, 2009, 3 (02):
  • [29] Sterol 14-demethylase P450(CYP51)
    Yoshida, Y
    NIPPON NOGEIKAGAKU KAISHI-JOURNAL OF THE JAPAN SOCIETY FOR BIOSCIENCE BIOTECHNOLOGY AND AGROCHEMISTRY, 1999, 73 (10): : 1026 - 1029
  • [30] Synthesis of novel triazole derivatives as inhibitors of cytochrome P450 14α-demethylase (CYP51)
    Sun, Qing-Yan
    Xu, Han-Ming
    Cao, Yong-Bing
    Zhang, Wan-Nian
    Wu, Qiu-Ye
    Zhang, Da-Zhi
    Zhang, Jun
    Zhao, Hui-Qing
    Jiang, Yaan-Ying
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2007, 42 (09) : 1226 - 1233